Characterization of childhood precursor T‐lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: A report from the Children's Oncology Group

T‐lymphoblastic lymphoma (T‐LBL) accounts for 25–30% of childhood non‐Hodgkin's lymphoma and is closely related to T‐lymphoblastic leukemia (T‐ALL). Recently, we demonstrated distinct differences in gene expression between childhood T‐LBL and T‐ALL, but molecular pathogenesis and relevant protein expression patterns in T‐LBL remain poorly understood.

[1]  Adam A. Margolin,et al.  NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth , 2006, Proceedings of the National Academy of Sciences.

[2]  S. Perkins,et al.  Results of CCG-5941: Intensified Multiagent Chemotherapy and Non-Cross Resistant Maintenance Therapy for Advanced Lymphoblastic Lymphoma in Children and Adolescents. , 2006 .

[3]  M. Bhasin,et al.  Notch1 Contributes to Mouse T-Cell Leukemia by Directly Inducing the Expression of c-myc , 2006, Molecular and Cellular Biology.

[4]  A. Hagemeijer,et al.  Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast , 2006, Leukemia.

[5]  S. Perkins,et al.  Gene expression profiling reveals intrinsic differences between T‐cell acute lymphoblastic leukemia and T‐cell lymphoblastic lymphoma , 2006, Pediatric blood & cancer.

[6]  J. Aster,et al.  c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. , 2006, Genes & development.

[7]  F. Speleman,et al.  Molecular cytogenetic study of 126 unselected T-ALL cases reveals high incidence of TCRβ locus rearrangements and putative new T-cell oncogenes , 2006, Leukemia.

[8]  S. Perkins,et al.  Childhood and adolescent non‐Hodgkin lymphoma: New insights in biology and critical challenges for the future , 2005, Pediatric blood & cancer.

[9]  S. Armstrong,et al.  Molecular genetics of acute lymphoblastic leukemia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Michael A. Teitell,et al.  The TCL1 family of oncoproteins: co-activators of transformation , 2005, Nature Reviews Cancer.

[11]  S. Perkins,et al.  Advances in the diagnostic approach to childhood lymphoblastic malignant neoplasms. , 2004, American journal of clinical pathology.

[12]  M. Manns,et al.  Skp2-dependent degradation of p27kip1 is essential for cell cycle progression. , 2004, Genes & development.

[13]  K. Bhatia,et al.  Expression of P53 and Bcl-2 Proteins in T-cell Lymphoblastic Lymphoma: Prognostic Implications , 2002, Leukemia & lymphoma.

[14]  J. Shuster,et al.  New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. , 2000, Blood.

[15]  Y. Hayashi,et al.  Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. , 1999, Leukemia research.

[16]  N. Heerema,et al.  Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  P. Steinherz,et al.  Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  M. Piris,et al.  The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations. , 1993, Blood.

[19]  W. Sanger,et al.  Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08. , 2007, Cancer genetics and cytogenetics.

[20]  P. Marynen,et al.  Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia. , 2005, Haematologica.

[21]  E. Cesarman,et al.  BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus. , 2001, Blood.